These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1256 related articles for article (PubMed ID: 11172484)
1. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484 [TBL] [Abstract][Full Text] [Related]
2. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Attman PO; Alaupovic P; Tavella M; Knight-Gibson C Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654 [TBL] [Abstract][Full Text] [Related]
3. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067 [TBL] [Abstract][Full Text] [Related]
4. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799 [TBL] [Abstract][Full Text] [Related]
5. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416 [TBL] [Abstract][Full Text] [Related]
6. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Marcoux C; Tremblay M; Fredenrich A; Jacques H; Krimbou L; Nakajima K; Davignon J; Cohn JS Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904 [TBL] [Abstract][Full Text] [Related]
7. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247 [TBL] [Abstract][Full Text] [Related]
8. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype. Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888 [TBL] [Abstract][Full Text] [Related]
10. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects. Dinkel RE; Barrett PH; Demant T; Parhofer KG Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589 [TBL] [Abstract][Full Text] [Related]
11. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. Marcoux C; Tremblay M; Nakajima K; Davignon J; Cohn JS J Lipid Res; 1999 Apr; 40(4):636-47. PubMed ID: 10191287 [TBL] [Abstract][Full Text] [Related]
12. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431 [TBL] [Abstract][Full Text] [Related]
13. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
14. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
15. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women. El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656 [TBL] [Abstract][Full Text] [Related]
17. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]
18. Recent progress in the development of radioimmunoassays for human serum lipoproteins. Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163 [TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. Campos H; Perlov D; Khoo C; Sacks FM J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625 [TBL] [Abstract][Full Text] [Related]
20. Human intestinal lipoproteins. Studies in chyluric subjects. Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]